12-hydroxy-5-8-10-14-eicosatetraenoic-acid and Coronary-Artery-Disease

12-hydroxy-5-8-10-14-eicosatetraenoic-acid has been researched along with Coronary-Artery-Disease* in 1 studies

Other Studies

1 other study(ies) available for 12-hydroxy-5-8-10-14-eicosatetraenoic-acid and Coronary-Artery-Disease

ArticleYear
12S-hydroxyeicosatetraenoic acid levels link to coronary artery disease in Type 2 diabetic patients.
    Journal of endocrinological investigation, 2013, Volume: 36, Issue:6

    12(S)-Hydroxyeicosatetraenoic acid (12(S)-HETE) is a metabolite of arachidonic acid. 12(S)-HETE is involved in the pathogenesis of atherosclerosis and diabetes. However, the correlation between 12(S)-HETE and coronary artery disease (CAD) in the diabetic patient is unclear.. The study investigated the relationship between 12(S)-HETE and CAD in Type 2 diabetes (T2D).. Plasma 12(S)- HETE levels were detected by enzyme-linked immunosorbent assay in 103 healthy controls (control), 109 diabetic patients without CAD (diabetic), and 152 diabetic patients with CAD (diabetic-CAD).. 12(S)-HETE levels were higher in both diabetic and diabetic-CAD groups compared to control and in the diabetic-CAD group compared to the diabetic group. In the multiple linear stepwise regression analysis, 12(S)-HETE levels correlated independently with CAD, systolic blood pressure, and glycated hemoglobin.. These results indicate that 12(S)-HETE levels are increased in diabetic patients with CAD, suggesting a role for atherosclerosis in T2D.

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Aged; Blood Pressure; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Regression Analysis; Risk Factors

2013